Molecular investigation into outbreak of HIV in a Scottish prison

Abstract Objectives: To support already established epidemiological links between inmates of Glenochil prison positive for HIV infection by using molecular techniques and thus provide evidence of the extent of acquisition during a recent outbreak of the disease resulting from needle sharing. To identify possible sources of the outbreak, and to demonstrate the ability of the methodology to make further links beyond the original outbreak. Design: Viral sequences obtained from the blood of HIV positive prisoners previously identified by standard epidemiological methods were compared with each other and with sequences from other Scottish patients. Setting: Glenochil prison for men, central Scotland. Subjects: Adult inmates and their possible contacts. Results: Phylogenetic analysis of viral sequences in two different genomic regions showed that 13 of the 14 HIV positive prisoners had been infected from a common source. Previous research had shown that six of these had acquired their infection in Glenochil; molecular evidence suggests that more than double this number were infected while incarcerated. Virus from two long term HIV positive patients who were in the prison at the time of the outbreak but who were not identified in the original or subsequent surveys was sufficiently different to make it unlikely that they were the source. A viral sequence from heterosexual transmission from one inmate showed the ability of these techniques to follow the infection through different routes of infection. Conclusion: The number of prisoners infected with HIV during the 1993 outbreak within Glenochil prison was more than twice that previously shown. This shows the potential for the spread of bloodborne diseases within prisons by injecting drugs. Key messages Originally, standard serological studies established that six out of 14 HIV positive people had acquired their infection in Glenochil prison in 1993 A subsequent survey estimated that up to 20 prisoners were HIV positive at that time Molecular linkage techniques showed that 13 of the original 14 infected men had viral sequences similar enough to indicate that one source of infection was common to all Molecular techniques provide a powerful epidemiological tool either to link or to distance infections with HIV Injecting drug use is a potentially explosive health care problem in prisons

[1]  M. Leinonen,et al.  Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study , 1997, BMJ.

[2]  M. Uhlén,et al.  Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Israel,et al.  Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. , 1996, The New England journal of medicine.

[4]  S. J. Clark,et al.  HIV-specific cellular and humoral immune responses in primary HIV infection. , 1996, AIDS research and human retroviruses.

[5]  R. Zuwallack,et al.  The effect of inhaled albuterol in moderate to severe asthma. , 1996, The Journal of allergy and clinical immunology.

[6]  J. Parry,et al.  Diverse HIV-1 genetic subtypes in UK , 1996, The Lancet.

[7]  G. Bentham Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales , 1996, BMJ.

[8]  G. Giles,et al.  Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? , 1996, British Journal of Cancer.

[9]  P. Hartge,et al.  Non-Hodgkin's lymphoma and sunlight. , 1996, Journal of the National Cancer Institute.

[10]  R. Osathanondh,et al.  HIV-1 Langerhans' Cell Tropism Associated with Heterosexual Transmission of HIV , 1996, Science.

[11]  D. Strachan,et al.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.

[12]  P. Hall,et al.  Non‐Hodgkin's lymphoma and skin malignancies‐shared etiology? , 1995, International journal of cancer.

[13]  B. Lipworth,et al.  Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients , 1995, The Lancet.

[14]  M. Melbye,et al.  Evidence of an association between non-Hodgkin's lymphoma and skin cancer , 1995, BMJ.

[15]  M. Dosemeci,et al.  United States non-Hodgkin's lymphoma surveillance by occupation 1984-1989: a twenty-four state death certificate study. , 1995, American journal of industrial medicine.

[16]  M. Ward The immunobiology and immunopathology of chlamydial infections , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  S. Gore,et al.  Drug injection and HIV prevalence in inmates of Glenochil prison , 1995, BMJ.

[18]  J. Wrench,et al.  Outbreak of HIV infection in a Scottish prison , 1995, BMJ.

[19]  S. Locarnini,et al.  Spread of bloodborne viruses among Australian prison entrants , 1995, BMJ.

[20]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[21]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[22]  D. Hendrick,et al.  Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. , 1994, American journal of respiratory and critical care medicine.

[23]  K. Jones,et al.  Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group. , 1994, Thorax.

[24]  M. Uhlén,et al.  Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes , 1994, Journal of virology.

[25]  N. Mueller Another view of the epidemiology of non-Hodgkin's lymphoma. , 1994, Oncology.

[26]  A. Staines,et al.  The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. , 1994, Leukemia & lymphoma.

[27]  P. Oakley The need for standards for inter‐hospital transfer , 1994, Anaesthesia.

[28]  C. Palmer,et al.  Rates of admission to hospital for asthma , 1994, BMJ.

[29]  S. Rennard,et al.  Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. , 1994, JAMA.

[30]  J. Huelsenbeck,et al.  Support for dental HIV transmission , 1994, Nature.

[31]  S. Gore,et al.  Study of infection with HIV and related risk factors in young offenders' institution. , 1993, BMJ.

[32]  S. Gore,et al.  No escape: HIV transmission in jail. , 1993, BMJ.

[33]  E. Holmes,et al.  Molecular investigation of human immunodeficiency virus (HIV) infection in a patient of an HIV-infected surgeon. , 1993, The Journal of infectious diseases.

[34]  E. Holmes,et al.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection , 1993, Journal of virology.

[35]  W. Castle,et al.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. , 1993, BMJ.

[36]  M. Uhlén,et al.  Forensic evidence by DNA sequencing , 1993, Nature.

[37]  J. Palmer,et al.  Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. , 1993, Thorax.

[38]  J. Kemp,et al.  A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. , 1992, The New England journal of medicine.

[39]  P. Barnes,et al.  Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma , 1992 .

[40]  P. Scherr,et al.  Non-Hodgkin's lymphoma and occupational exposure. , 1992, Cancer research.

[41]  T. Fears,et al.  Non-Hodgkin's lymphoma time trends: United States and international data. , 1992, Cancer research.

[42]  P. Hartge,et al.  Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. , 1992, Cancer research.

[43]  A. Blair,et al.  Pesticides and non-Hodgkin's lymphoma. , 1992, Cancer research.

[44]  J. Palmer,et al.  A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group. , 1992, The European respiratory journal.

[45]  S. Gore,et al.  Anonymous HIV surveillance in Saughton Prison, Edinburgh , 1992, AIDS.

[46]  J. Mullins,et al.  Molecular Epidemiology of HIV Transmission in a Dental Practice , 1992, Science.

[47]  T. Mackay,et al.  Factors Affecting Asthma Mortality in Scotland , 1992, Scottish Medical Journal.

[48]  P. Simmonds,et al.  Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis , 1991, Journal of virology.

[49]  R. Dahl,et al.  Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. , 1991, The European respiratory journal.

[50]  J. Matthews,et al.  Serial correlation in the design and analysis of crossover trials , 1991 .

[51]  R. Douglas,et al.  HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. , 1991, AIDS.

[52]  P. Simmonds,et al.  Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. , 1991, AIDS.

[53]  D. Vlahov,et al.  Prevalence of antibody to HIV-1 among entrants to US correctional facilities. , 1991, JAMA.

[54]  N. Douglas,et al.  Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. , 1990, BMJ.

[55]  T Gojobori,et al.  Molecular clock of viral evolution, and the neutral theory. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Elwood,et al.  Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. , 1990, International journal of epidemiology.

[57]  B. Pasternack,et al.  Simultaneous assessment of risk factors for malignant melanoma and non-melanoma skin lesions, with emphasis on sun exposure and related variables. , 1990, International journal of epidemiology.

[58]  T. Pumarola,et al.  Seroepidemiology of HIV-1 infection in a Catalonian penitentiary. , 1990, AIDS.

[59]  E. White,et al.  Melanoma risk by age and socio‐economic status , 1990, International journal of cancer.

[60]  G. Hart,et al.  Risk behaviours for HIV infection among drug users in prison. , 1990, BMJ.

[61]  R N Hoover,et al.  The emerging epidemic of melanoma and squamous cell skin cancer. , 1989, JAMA.

[62]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure , 1988, International journal of cancer.

[63]  A. Tattersfield,et al.  REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINE , 1988, The Lancet.

[64]  I. Ledingham,et al.  Provision of facilities for secondary transport of seriously ill patients in the United Kingdom , 1988, British medical journal.

[65]  J. Bion,et al.  Transporting critically ill patients by ambulance: audit by sickness scoring , 1988, British medical journal.

[66]  P. Burney,et al.  ASTHMA MORTALITY IN ENGLAND AND WALES: EVIDENCE FOR A FURTHER INCREASE, 1974-84 , 1986, The Lancet.

[67]  J. Elwood,et al.  Cutaneous melanoma in relation to intermittent and constant sun exposure—the western canada melanoma study , 1985, International journal of cancer.

[68]  Association of Anaesthetists of Great Britain and Ireland , 1985 .

[69]  R. Burn,et al.  Seasonal variation and time trends of deaths from asthma in England and Wales 1960-82. , 1984, British medical journal.

[70]  J J Spinelli,et al.  Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. , 1984, British medical journal.

[71]  A. Woolcock,et al.  Rapid method for measurement of bronchial responsiveness. , 1983, Thorax.

[72]  O. Miettinen,et al.  An alternative to the proportionate mortality ratio. , 1981, American journal of epidemiology.

[73]  D. Strickland,et al.  Malignant melanoma: social status and outdoor work. , 1980, British Journal of Cancer.

[74]  L W Green,et al.  Manual for scoring socioeconomic status for research on health behavior. , 1970, Public health reports.

[75]  J. Gallin,et al.  Serum lipids in infection. , 1969, The New England journal of medicine.

[76]  P. Walford Deaths from asthma. , 1968, British medical journal.

[77]  Samuel L. Groseclose,et al.  Summary of Notifiable Diseases, United States. , 1997 .

[78]  P. Simmonds,et al.  Sequence analysis of virus variability based on PCR , 1995 .

[79]  P. Simmonds,et al.  HIV: A Practical Approach , 1995 .

[80]  G. Guyatt,et al.  Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. , 1995, American journal of respiratory and critical care medicine.

[81]  J. Hedner,et al.  Inhaled Salmeterol and Salbutamol in Asthmatic Patients , 1990 .

[82]  A. Mindel Virology and Immunology , 1989 .

[83]  C. Garland,et al.  Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.